JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

AcelRx Pharmaceuticals Inc

Cerrado

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+532.91% upside

AcelRx Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

29 oct 2025, 23:28 UTC

Acciones populares

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

29 oct 2025, 23:07 UTC

Ganancias

Prudential PLC 3Q New Business Profit Up 13%

30 oct 2025, 00:00 UTC

Ganancias

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

30 oct 2025, 00:00 UTC

Ganancias

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

30 oct 2025, 00:00 UTC

Ganancias

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

29 oct 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

29 oct 2025, 23:40 UTC

Ganancias

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

29 oct 2025, 23:38 UTC

Charlas de Mercado

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

29 oct 2025, 23:25 UTC

Ganancias

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

29 oct 2025, 22:51 UTC

Ganancias

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

29 oct 2025, 22:45 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

29 oct 2025, 22:41 UTC

Ganancias

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

29 oct 2025, 22:41 UTC

Ganancias

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

29 oct 2025, 22:09 UTC

Ganancias

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

29 oct 2025, 22:08 UTC

Charlas de Mercado
Ganancias

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

29 oct 2025, 21:58 UTC

Ganancias

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

29 oct 2025, 21:58 UTC

Ganancias

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

29 oct 2025, 21:57 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

29 oct 2025, 21:54 UTC

Ganancias

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

29 oct 2025, 21:46 UTC

Ganancias

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

29 oct 2025, 21:43 UTC

Ganancias

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

29 oct 2025, 21:43 UTC

Ganancias

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

29 oct 2025, 21:42 UTC

Ganancias

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

29 oct 2025, 21:42 UTC

Ganancias

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

29 oct 2025, 21:41 UTC

Ganancias

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

29 oct 2025, 21:41 UTC

Ganancias

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

29 oct 2025, 21:41 UTC

Ganancias

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

29 oct 2025, 21:41 UTC

Ganancias

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

29 oct 2025, 21:40 UTC

Ganancias

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

29 oct 2025, 21:39 UTC

Ganancias

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Comparación entre iguales

Cambio de precio

AcelRx Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

532.91% repunte

Estimación a 12 meses

Media 5 USD  532.91%

Máximo 5 USD

Mínimo 5 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AcelRx Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Finanzas

$

help-icon Live chat